New Delhi: The Oxford University and AstraZeneca vaccine trial has recently been halted due to a patient’s poor health. However, it is now reported that Astrazeneca has resumed trial of the Corona vaccine in the UK. According to the company, after receiving approval from the UK’s Medicine Health Regulatory Authority, the vaccine trial has restarted. Significantly, the vaccine trial was stopped first in the UK and then worldwide after the health of 1 volunteer in the UK deteriorated.
A recent statement has come about the vaccine, stating that the company stopped the vaccine trial on Sept. 6 after an adverse reaction occurred in a patient and asked the independent committee to investigate it. Now this investigation has been completed and the company has received approval to restart the trial.
Also read – Good news: Corona medicine made in India? Vaccine test on animals successful
The regulator says side effects are normal in one or two patients. For your information, let us know that Serum Institute of India is also testing this vaccine in India.
On Thursday, the Serum Institute of India released a statement saying, “We are reviewing the situation and are delaying the trial in India for the time being.” Serum is the largest vaccine manufacturing company in the world by volume.